Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

Pfizer Inc. (PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC (GB:HLN). With this transaction, Pfizer’s ownership in Haleon has been reduced to 15% ...

During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...

Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts.

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by selling £2.45B ($3.26B) worth of company shares, Reuters reported ...

Pfizer Inc. is poised to raise about £2.7 billion ($3.6 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health giant. The US company increased the ...

(Bloomberg) -- Pfizer Inc. has raised about £2.4 billion ($3.2 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health company. The US ...

In a move to fulfill its shareholder return commitments, Haleon plc (LSE/NYSE: HLN), a leader in the consumer health industry, has completed an off-market purchase of shares from Pfizer Inc. (NYSE ...

Pfizer, which is under pressure from activist investor Starboard, on Tuesday (Oct 29) topped third-quarter estimates as sales of its Covid-19 treatment Paxlovid blew past Wall Street expectations.

Pfizer (NYSE: PFE) is in that group, in my opinion. The big drugmaker's forward dividend yield currently stands at just under ...